BTIG cuts Avalo Therapeutics target price to $10 from $58
AVTX•BTIG cut its target price for Avalo Therapeutics to $10 from $58.
Related News
Honeywell Technologies: Daiwa Capital Markets cuts target price to $250 from $277
HON•
JPMorgan cuts Union Pacific target price to $321 from $322
UNP•
Waste Connections target price raised to $207 from $184
WCN•
Fiera Capital Corporation target price cut to C$3.50 from C$5.00
FSZ•
Associated Banc-Corp: RBC raises target price to $34 from $33
ASB•